查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830951

心血管超音波心臟檢查市場

Cardiovascular Echocardiography Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

心血管超音波心臟檢查市場預計將從 2024 年的 1.5437 億美元成長到 2031 年的 2.2214 億美元，預計 2025 年至 2031 年的複合年成長率為 5.5%。

市場洞察與分析師觀點：心血管超音波心動圖是一種用於評估心臟的醫學影像技術。它利用聲波產生心臟結構的視覺影像。此檢查通常用於疑似或確診心臟病的患者。除了提供心腔和瓣膜的大小和形狀資訊外，它還透過測量心輸出量、射血分數和舒張功能來評估心臟功能。超音波心動圖可以識別心肌病變，並可視化先前心臟病發作造成的損傷。各種心臟超音波檢查，包括經胸超音波心臟檢查、經食道心臟超音波和負荷超音波心動圖，都可用於診斷。心血管疾病盛行率的不斷上升和老齡人口的不斷成長預計將為心血管超音波心動圖市場創造巨大的成長機會。

成長促進因素：在評估心臟病發作、胸痛、冠狀動脈疾病、血栓和其他心臟問題時，醫生通常會建議進行涉及血液檢查和心導管插入術的侵入性操作。這種侵入性方法需要延長住院時間，並可能導致出血、血栓和動脈損傷等併發症。因此，醫師傾向於限制使用心導管插入術進行心臟診斷，轉而選擇非侵入性方法，例如核心髒壓力測試、磁振造影、心臟超音波和冠狀動脈CT血管攝影。

超音波心動圖是繼心電圖和胸部X光之後最常用的心血管診斷方法。它是一種非侵入性檢查，能夠提供關於心臟功能和血流動力學的寶貴資訊。與其他使用放射線的診斷方法相比，超音波心動圖的風險極低，因此已被醫院和診斷中心廣泛採用。此外，有心臟衰竭病史的患者可以透過這些診斷方法進行定期監測，從而受益，這有助於追蹤病情進展和治療效果。超音波心動圖也用於有心臟毒性風險的癌症患者的持續護理。

超音波心動圖設備相對於其他心臟診斷方法的優勢推動了其被採用，從而推動了心血管超音波心動圖市場的成長。

心血管超音波心動圖市場的當前趨勢包括將人工智慧和其他尖端技術整合到超音波心動圖設備中。

戰略洞察

報告細分和範圍：心血管超音波心動圖市場分析涵蓋以下幾個方面：類型、技術、最終用戶和地理。依類型分類，市場分為經胸超音波心臟檢查、經食道超音波心動圖、負荷超音波心動圖和胎兒超音波心臟檢查。依技術分類，市場分為2D超音波心動圖、3D超音波心動圖和多普勒超音波心動圖。依最終用戶分類，市場分為醫院、門診手術中心和診斷實驗室。心血管超音波心動圖市場報告的地理範圍包括北美（美國、加拿大和墨西哥）、歐洲（法國、德國、英國、西班牙、義大利和歐洲其他地區）、亞太地區（中國、日本、印度、澳洲、韓國和亞太其他地區）、中東和非洲（沙烏地阿拉伯、南非、阿拉伯聯合大公國和中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和中美洲）。

細分分析：心血管超音波心臟檢查市場依類型分為經胸超音波心臟檢查、負荷超音波心動圖、經食道心臟超音波和胎兒超音波心臟檢查。經胸超音波心臟檢查細分市場在2022年佔據了相當大的市場佔有率，預計在2022年至2030年期間將呈現最高的複合年成長率。

依技術分類，市場分為2D超音波心動圖、3D超音波心動圖和多普勒超音波心動圖。 2022年，3D超音波心動圖佔據了心血管超音波心動圖市場的很大佔有率，預計在2022年至2030年期間將實現最高的複合年成長率。

依最終用戶分類，市場分為醫院、門診手術中心和診斷實驗室。 2022年，醫院市場在心血管超音波心動圖市場中佔據了相當大的佔有率，預計在2022年至2030年期間將實現最高的複合年成長率。

心血管超音波心動圖市場報告範圍

區域分析：心血管超音波心臟檢查市場按區域分類，可分為北美、歐洲、亞太地區、南美和中美以及中東和非洲。 2022年，北美佔據了相當大的市場佔有率，其中美國在該區域處於領先地位。北美市場的成長歸因於心臟病發病率的上升、老齡人口的增加以及該地區主要市場參與者的存在。

心臟病是美國的主要死因。根據美國疾病管制與預防中心 (CDC) 的數據，美國每年約有 805,000 人心臟病發作。此外，冠狀動脈心臟病是最常見的心臟病形式，2019 年導致 360,900 人死亡。 CDC 估計，到 2030 年，美國將有約 1,210 萬人患有心房顫動。同樣，加拿大慢性疾病監測系統報告稱，大約每 12 個（260 萬）20 歲及以上的加拿大成年人中就有 1 個被診斷患有心臟病。加拿大統計局表示，2020 年有 67,399 人死於心臟病或中風。因此，心血管疾病盛行率的上升影響了很大一部分人口，導致對心血管超音波心動圖等診斷工具的需求增加，以評估和監測心血管健康，從而推動了該地區的市場發展。

競爭格局與關鍵參與者：心血管超音波心動圖市場的預測可以幫助利害關係人制定成長策略。心血管超音波心臟檢查市場報告中介紹的主要參與者包括Apex Heart and Vascular、Ultra-X Imaging、Metropolitan Heart Vascular Institute、Ultromics Limited、Corewell Health、Centinela Hospital Medical Center、Schoolcraft Memorial Hospital、猶他大學健康中心、Goshen Heart & Vascular Center和Harefield Hospitalcular Center和Harefield Hospitalcular Center。這些公司專注於推出新的高科技產品、增強現有產品組合併拓展地理範圍，以滿足日益成長的全球消費者需求。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：心血管超音波心臟檢查市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：心血管超音波心臟檢查市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：心血管超音波心臟檢查市場-全球市場分析

  • 心血管超音波心臟檢查 - 全球市場概覽
  • 心血管超音波心臟檢查—全球市場及2031年預測

第7章：心血管超音波心臟檢查市場-收入分析-依類型，2021-2031

  • 概述
  • 經胸超音波心臟檢查
  • 經食道心臟超音波
  • 負荷超音波心臟檢查
  • 胎兒超音波心臟檢查

第 8 章：心血管超音波心動圖市場 - 收入分析 - 按技術，2021-2031 年

  • 概述
  • 2D超音波心動圖
  • 3D超音波心臟檢查
  • 多普勒

第 9 章：心血管超音波心動圖市場 - 收入分析 - 按最終用戶，2021-2031 年

  • 概述
  • 醫院
  • 門診手術中心
  • 診斷實驗室

第 10 章：心血管超音波心動圖市場 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 12 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 13 章：心血管超音波心動圖市場 - 主要公司簡介

  • Apex Heart and Vascular
  • Ultra-X Imaging
  • Metropolitan Heart Vascular Institute
  • Ultromics Limited
  • Corewell Health
  • Centinela Hospital Medical Center
  • Schoolcraft Memorial Hospital
  • University of Utah Health
  • Goshen Heart and Vascular Center
  • Harefield Hospital

第 14 章：附錄

簡介目錄
Product Code: TIPHE100000964

The cardiovascular echocardiography market is anticipated to grow to US$ 222.14 million by 2031, up from US$ 154.37 million in 2024, reflecting a projected CAGR of 5.5% from 2025 to 2031.

Market Insights and Analyst Perspective:Cardiovascular echocardiography is a medical imaging technique used to assess the heart. It employs sound waves to generate visual representations of the heart's structure. This procedure is typically conducted on patients with suspected or confirmed heart conditions. In addition to providing information about the size and shape of the heart's chambers and valves, it also evaluates heart function by measuring cardiac output, ejection fraction, and diastolic function. Echocardiograms can identify cardiomyopathies and visualize damage from previous heart attacks. Various cardiac ultrasound tests, including transthoracic, transesophageal, and stress echocardiography, are performed for diagnostic purposes. The increasing prevalence of cardiovascular diseases and the expanding elderly population are expected to create significant growth opportunities for the cardiovascular echocardiography market.

Factors Driving Growth:In the assessment of heart attacks, chest pain, coronary artery disease, blood clots, and other cardiac issues, physicians often recommend invasive procedures that involve blood tests and cardiac catheterization. This invasive approach requires extended hospital stays and can lead to complications such as bleeding, blood clots, and arterial damage. Consequently, doctors tend to limit the use of catheterization for cardiac diagnosis, opting instead for noninvasive alternatives like nuclear cardiac stress tests, magnetic resonance imaging, cardiac ultrasound, and coronary computed tomography angiograms.

Echocardiography ranks as the most frequently utilized cardiovascular diagnostic test following electrocardiography and chest X-rays. It is a noninvasive procedure that provides valuable insights into cardiac function and hemodynamics. Given the minimal risks associated with echocardiograms compared to other diagnostic methods that utilize radiation, there has been widespread adoption of these devices in hospitals and diagnostic centers. Additionally, patients with a history of heart failure benefit from regular monitoring through these diagnostics, which aids in tracking disease progression and treatment efficacy. Echocardiograms are also employed in the ongoing care of cancer patients at risk of cardiotoxicity.

The benefits of echocardiographic devices over other cardiac diagnostic methods drive their adoption, thus propelling the growth of the cardiovascular echocardiography market.

Current trends in the cardiovascular echocardiography market include the integration of AI and other cutting-edge technologies into echocardiography devices.

Strategic Insights

Report Segmentation and Scope:The analysis of the cardiovascular echocardiography market has been conducted by examining the following segments: type, technology, end user, and geography. By type, the market is divided into transthoracic echocardiography, transesophageal echocardiography, stress echocardiography, and fetal echocardiography. In terms of technology, the market is categorized into 2D echocardiograms, 3D echocardiograms, and Doppler echocardiograms. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, and diagnostic laboratories. The geographical scope of the cardiovascular echocardiography market report includes North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:The cardiovascular echocardiography market is categorized by type into transthoracic echocardiography, stress echocardiography, transesophageal echocardiography, and fetal echocardiography. The transthoracic echocardiography segment held a substantial market share in 2022 and is expected to exhibit the highest CAGR during the period from 2022 to 2030.

In terms of technology, the market is divided into 2D echocardiograms, 3D echocardiograms, and Doppler echocardiograms. The 3D echocardiogram segment accounted for a significant share of the cardiovascular echocardiography market in 2022 and is projected to achieve the highest CAGR from 2022 to 2030.

By end user, the market is segmented into hospitals, ambulatory surgery centers, and diagnostic laboratories. The hospitals segment represented a significant share of the cardiovascular echocardiography market in 2022 and is anticipated to register the highest CAGR during the period from 2022 to 2030.

Cardiovascular Echocardiography Market Report Scope

Regional Analysis:Regionally, the cardiovascular echocardiography market is divided into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held a considerable share of the market, with the US leading in this region. The growth of the market in North America is attributed to the rising incidence of heart diseases, an increasing elderly population, and the presence of major market players in the area.

Heart disease is a leading cause of mortality in the US. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 individuals experience a heart attack annually in the US. Furthermore, coronary heart disease is the most prevalent form of heart disease, resulting in 360,900 deaths in 2019. The CDC estimates that by 2030, around 12.1 million people in the US will have atrial fibrillation. Similarly, the Canadian Chronic Disease Surveillance System reports that about 1 in 12 (2.6 million) Canadian adults aged 20 and older are diagnosed with heart disease. Statistics Canada indicates that 67,399 individuals died from heart disease or stroke in 2020. Thus, the increasing prevalence of cardiovascular diseases impacts a large segment of the population, leading to heightened demand for diagnostic tools like cardiovascular echocardiography to evaluate and monitor cardiovascular health, thereby driving the market in the region.

Competitive Landscape and Key Players:The forecast for the cardiovascular echocardiography market can assist stakeholders in formulating their growth strategies. Key players profiled in the cardiovascular echocardiography market report include Apex Heart and Vascular, Ultra-X Imaging, Metropolitan Heart Vascular Institute, Ultromics Limited, Corewell Health, Centinela Hospital Medical Center, Schoolcraft Memorial Hospital, University of Utah Health, Goshen Heart & Vascular Center, and Harefield Hospital. These companies are focused on launching new high-tech products, enhancing existing offerings, and expanding geographically to meet the increasing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Cardiovascular Echocardiography Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Cardiovascular Echocardiography Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cardiovascular Echocardiography Market - Global Market Analysis

  • 6.1 Cardiovascular Echocardiography - Global Market Overview
  • 6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031

7. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 7.1 Overview
  • 7.2 Transthoracic Echocardiography
  • 7.3 Transesophageal Echocardiography
  • 7.4 Stress Echocardiography
  • 7.5 Fetal Echocardiography

8. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By Technology, 2021-2031

  • 8.1 Overview
  • 8.2 2D echocardiogram
  • 8.3 3D echocardiogram
  • 8.4 Doppler

9. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Diagnostic Labs

10. Cardiovascular Echocardiography Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Cardiovascular Echocardiography Market Overview
    • 10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
    • 10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
    • 10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Cardiovascular Echocardiography Market
        • 10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
        • 10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
      • 10.1.6.2 Canada Cardiovascular Echocardiography Market
        • 10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
        • 10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
      • 10.1.6.3 Mexico Cardiovascular Echocardiography Market
        • 10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
        • 10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
        • 10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Cardiovascular Echocardiography Market - Key Company Profiles

  • 13.1 Apex Heart and Vascular
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ultra-X Imaging
  • 13.3 Metropolitan Heart Vascular Institute
  • 13.4 Ultromics Limited
  • 13.5 Corewell Health
  • 13.6 Centinela Hospital Medical Center
  • 13.7 Schoolcraft Memorial Hospital
  • 13.8 University of Utah Health
  • 13.9 Goshen Heart and Vascular Center
  • 13.10 Harefield Hospital

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud